Multiple human papillomavirus infections and HIV seropositivity as risk factors for abnormal cervical cytology among female sex workers in Nairobi

International Journal of STD and AIDS

Volumn 24, Issue 3, 2013, Pages 221-225

  Patel, S J ^a   Mugo, N R ^b   Cohen, C R ^a   Ting, J ^c   Nguti, R ^b   Kwatampora, J ^b   Waweru, W ^b   Patnaik, P ^c   Donders, G G ^d,e   Kimani, J ^b   Kenney, D L ^f   Kiviat, N B ^f   Smith, J S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Femicare vzw   (Belgium)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Africa; Cervical dysplasia; HIV; HPV; Human papillomavirus; Sex workers; Sexually transmitted infection

Indexed keywords

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; KENYA; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX DISEASE; WART VIRUS;

AFRICA; CERVICAL DYSPLASIA; HIV; HPV; HUMAN PAPILLOMAVIRUS; SEX WORKERS; SEXUALLY TRANSMITTED INFECTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMAN PAPILLOMAVIRUS 16; HUMANS; KENYA; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREVALENCE; RISK FACTORS; SEX WORKERS; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84890143620     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462412472446     Document Type: Article

References (21)

1. Chirenje ZM. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol 2005;19:269-76
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917
3. Chan DJ. Fatal attraction: sex, sexually transmitted infections and HIV-1. Int J STD AIDS 2006;17:643-51
4. Sangani P, Rutherford G, Wilkinson D. Population-based interventions for reducing sexually transmitted infections, including HIV infection. Cochrane Database Syst Rev 2004;2:CD001220
5. Langley CL, Benga-De E, Critchlow CW, et al. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women. AIDS 1996;10:413-7
6. Marais DJ, Vardas E, Ramjee G, et al. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions. J Infect Dis 2000;182:1239-42
7. De Marco F, Houissa-Kchouk F, Khelifa R, et al. High-risk HPV types in Tunisia. A pilot study reveals an unexpectedly high prevalence of types 58 and 82 and lack of HPV 18 among female prostitutes. J Med Virol 2006;78:950-3
8. Laga M, Icenogle JP, Marsella R, et al. Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int J Cancer 1992;50:45-8
9. Luchters SM, Vanden Boeck D, Chersich MF, et al. Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis 2010;10:1-10
10. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002;89:191-9
11. Smith JS, Bosetti C, Munoz N, Herrero R, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431-9
12. World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases: Overview and Estimates. WHO Dept of HIV/AIDS, 2001. http://www.who.int/hiv/pub/sti/who_hiv_aids_2001. 02.pdf (last accessed 5 January 2013)
13. Manhart LE, Holmes KK, Koutsky L, et al. Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis 2006;33:502-8
14. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9
15. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma. J Infect Dis 2005;192:591-9
16. Donders GG. Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 2007;3:355-73
17. Schmidt H, Hansen JG. Validity of wet-mount bacterial morphotype identification of vaginal fluid by phase-contrast microscopy for diagnosis of bacterial vaginosis in family practice. APMIS 2001;109:589-94
18. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121:621-32
19. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8
20. De Vuyst H, Steyaert S, Van Renterghem L, et al. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis 2003;30:137-42
21. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006;15:1274-80